Literature DB >> 21123862

Pathology of GM2 gangliosidosis in Jacob sheep.

B F Porter1, B C Lewis, J F Edwards, J Alroy, B J Zeng, P A Torres, K N Bretzlaff, E H Kolodny.   

Abstract

The G(M2) gangliosidoses are a group of lysosomal storage diseases caused by defects in the genes coding for the enzyme hexosaminidase or the G(M2) activator protein. Four Jacob sheep from the same farm were examined over a 3-year period for a progressive neurologic disease. Two lambs were 6-month-old intact males and 2 were 8-month-old females. Clinical findings included ataxia in all 4 limbs, proprioceptive deficits, and cortical blindness. At necropsy, the nervous system appeared grossly normal. Histologically, most neurons within the brain, spinal cord, and peripheral ganglia were enlarged, and the cytoplasm was distended by foamy to granular material that stained positively with Luxol fast blue and Sudan black B stains. Other neuropathologic findings included widespread astrocytosis, microgliosis, and scattered spheroids. Electron microscopy revealed membranous cytoplasmic bodies within the cytoplasm of neurons. Biochemical and molecular genetic studies confirmed the diagnosis of G(M2) gangliosidosis. This form of G(M2) gangliosidosis in Jacob sheep is very similar to human Tay-Sachs disease and is potentially a useful animal model.
© The Authors 2011

Entities:  

Mesh:

Year:  2010        PMID: 21123862     DOI: 10.1177/0300985810388522

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  15 in total

Review 1.  The GM1 and GM2 Gangliosidoses: Natural History and Progress toward Therapy.

Authors:  Debra S Regier; Richard L Proia; Alessandra D'Azzo; Cynthia J Tifft
Journal:  Pediatr Endocrinol Rev       Date:  2016-06

2.  Gene transfer corrects acute GM2 gangliosidosis--potential therapeutic contribution of perivascular enzyme flow.

Authors:  M Begoña Cachón-González; Susan Z Wang; Rosamund McNair; Josephine Bradley; David Lunn; Robin Ziegler; Seng H Cheng; Timothy M Cox
Journal:  Mol Ther       Date:  2012-03-27       Impact factor: 11.454

3.  Natural history of Tay-Sachs disease in sheep.

Authors:  Brett Story; Toloo Taghian; Jillian Gallagher; Jey Koehler; Amanda Taylor; Ashley Randle; Kayly Nielsen; Amanda Gross; Annie Maguire; Sara Carl; Siauna Johnson; Deborah Fernau; Elise Diffie; Paul Cuddon; Carly Corado; Sundeep Chandra; Miguel Sena-Esteves; Edwin Kolodny; Xuntian Jiang; Douglas Martin; Heather Gray-Edwards
Journal:  Mol Genet Metab       Date:  2021-08-21       Impact factor: 4.204

Review 4.  Therapeutic Strategies For Tay-Sachs Disease.

Authors:  Jaqueline A Picache; Wei Zheng; Catherine Z Chen
Journal:  Front Pharmacol       Date:  2022-07-05       Impact factor: 5.988

5.  Reversibility of neuropathology in Tay-Sachs-related diseases.

Authors:  María-Begoña Cachón-González; Susan Z Wang; Robin Ziegler; Seng H Cheng; Timothy M Cox
Journal:  Hum Mol Genet       Date:  2013-09-20       Impact factor: 6.150

Review 6.  Animal models of GM2 gangliosidosis: utility and limitations.

Authors:  Cheryl A Lawson; Douglas R Martin
Journal:  Appl Clin Genet       Date:  2016-07-20

7.  Occipital condylar dysplasia in a Jacob lamb (Ovis aries).

Authors:  Alison M Lee; Nicola F Fletcher; Conor Rowan; And Hanne Jahns
Journal:  Open Vet J       Date:  2017-05-20

Review 8.  New Approaches to Tay-Sachs Disease Therapy.

Authors:  Valeriya V Solovyeva; Alisa A Shaimardanova; Daria S Chulpanova; Kristina V Kitaeva; Lisa Chakrabarti; Albert A Rizvanov
Journal:  Front Physiol       Date:  2018-11-20       Impact factor: 4.566

Review 9.  Genetics and Therapies for GM2 Gangliosidosis.

Authors:  Maria Begona Cachon-Gonzalez; Eva Zaccariotto; Timothy Martin Cox
Journal:  Curr Gene Ther       Date:  2018       Impact factor: 4.391

Review 10.  Large animal models of rare genetic disorders: sheep as phenotypically relevant models of human genetic disease.

Authors:  Ashish R Pinnapureddy; Cherie Stayner; John McEwan; Olivia Baddeley; John Forman; Michael R Eccles
Journal:  Orphanet J Rare Dis       Date:  2015-09-02       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.